Anixa biosciences announces poster presentation on ovarian cancer car-t clinical trial at the american society of clinical oncology (asco) annual meeting

San jose, may 12, 2025 /prnewswire/ -- anixa biosciences, inc. ("anixa" or the "company") (nasdaq: anix), a biotechnology company focused on the treatment and prevention of cancer, today announced that dr. pamela d. garzone, chief development officer of anixa, will present a poster at the 2025 american society of clinical oncology (asco) annual meeting, taking place on may 30 – june 3, 2025, in chicago, illinois.
CAR Ratings Summary
CAR Quant Ranking